Pfizer, Moderna...they're all diving into cancer

Dr. William Makis: "You look at Pfizer, Moderna...they're all diving into cancer, that's going to be their number one revenue they say from 2025 to 2030...they recognize that these turbo cancers in Covid vaccinated individuals are resistant to standard chemotherapy, standard radiation therapy, so you need something to offer to patients, something new and of course it's going to be something extremely expensive."